Tuesday, October 05, 2004
HCA and Tennessee Oncology form Sarah Cannon Research Institute
From the Nashville Business Journal
HCA Inc. and Nashville-based Tennessee Oncology have partnered to create the Sarah Cannon Research Institute, a company that will focus on clinical trials for cancer patients.
"The Sarah Cannon Research Institute will take The Sarah Cannon Cancer Center to the next level of national prominence in cancer treatment and research," says Paul Rutledge, president of HCA's MidAmerica division.
Since the Sarah Cannon center began operations in 1991, it's medical director and physicians with Tennessee Oncology have developed the largest community-based clinical trial program in the country - the Minnie Pearl Cancer Research Network - made up of 76 private oncology groups with more than 500 oncologists conducting trials in 25 states.
Read the article
Nashville Business Journal
HCA Inc. and Nashville-based Tennessee Oncology have partnered to create the Sarah Cannon Research Institute, a company that will focus on clinical trials for cancer patients.
"The Sarah Cannon Research Institute will take The Sarah Cannon Cancer Center to the next level of national prominence in cancer treatment and research," says Paul Rutledge, president of HCA's MidAmerica division.
Since the Sarah Cannon center began operations in 1991, it's medical director and physicians with Tennessee Oncology have developed the largest community-based clinical trial program in the country - the Minnie Pearl Cancer Research Network - made up of 76 private oncology groups with more than 500 oncologists conducting trials in 25 states.
Read the article
Nashville Business Journal